Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience-Reference-Cited by-同舟云学术

Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience

Published:2020-07-16 Issue:6 Volume:192 Page:1049-1053
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Lewis Katharine L.¹²³^ORCID,Chin Collin K.⁴,Manos Kate⁵^ORCID,Casey John⁶,Hamad Nada⁷^ORCID,Crawford Julie¹⁸,Ho Shir‐Jing⁹,Issa Samar¹⁰,Grigg Andrew⁵^ORCID,Wood Peter¹¹,Gandhi Maher K.¹¹^ORCID,Do Bryan⁴^ORCID,Nastoupil Loretta⁴,Hawkes Eliza A.⁵¹²¹³,Cheah Chan Y.¹²³⁸^ORCID

Affiliation:

1. Department of Haematology Sir Charles Gairdner Hospital NedlandsWAAustralia

2. Medical School University of Western Australia NedlandsWAAustralia

3. Linear Clinical Research Nedlands WA Australia

4. Department of Lymphoma/Myeloma MD Anderson Cancer Center Houston TX USA

5. Department of Clinical Haematology Austin Health Heidelberg VICAustralia

6. Department of Haematology The Townsville Hospital Townsville QLDAustralia

7. Department of Haematology St Vincent’s HospitalUNSW Sydney NSWAustralia

8. Department of Haematology Pathwest Laboratory Medicine Perth WAAustralia

9. Department of Haematology St George Hospital Sydney NSWAustralia

10. Department of Haematology Middlemore Hospital Auckland New Zealand

11. Department of Haematology Princess Alexandra Hospital Brisbane QLDAustralia